Autoimmune hemolytic anemia is an infrequent complication following allogeneic hematopoietic stem cell transplantation. [1] [2] [3] Among the types of autoimmune hemolytic anemia, cold agglutinin disease (CAD) due to a coldreactive antibody is rarely reported. [1] [2] [3] [4] We describe here a case of CAD due to a cold-reactive anti-Pr antibody, which occurred simultaneously at the onset of adenovirus hemorrhagic cystitis after allogeneic bone marrow transplantation (BMT).
A 39-year-old female with myelodysplastic syndrome (refractory anemia) underwent allogeneic BMT from her one human leukocyte antigen (HLA) mismatched, ABOmatched sister. She was conditioned with total body irradiation (120 cGy) and cyclophosphamide (120 mg/kg), and received tacrolimus and short-term methotrexate as a prophylaxis for graft-versus-host disease (GVHD). She did not receive antithymocyte globulin, and bone marrow graft was not T-cell depleted. Her post-transplant course was not remarkable except for extensive-type chronic GVHD of the mouth, skin, and gastrointestinal tracts, diagnosed around day 160. Chronic GVHD responded well to systemic administration of corticosteroid and cyclosporine A (CSA). On day 240, when she was still on CSA and receiving tapering doses of corticosteroid without active chronic GVHD, she developed macroscopic hematuria accompanied by urinary urgency. Adenovirus (type 11) was detected in her urine by conventional qualitative polymerase chain reaction and shell vial assay. Detection of adenovirus in the urine and the urinary symptoms led to the diagnosis of adenovirus hemorrhagic cystitis. At the onset of hemorrhagic cystitis, the blood tests showed a rapidly progressing anemia (hemoglobin level decreased from 10.1 to 5.2 g/dL over 6 days) with marked reticulocytosis (13.1%). Her serum level of lactate dehydrogenase was 651 IU/l (normal range; 120-210 IU/l). Cold agglutinin was detected at the titer of 1:256 in the serum. Her direct antiglobulin test was strongly positive, attributable to complement (C3d); the indirect antiglobulin test also detected a free antibody in the serum. Agglutination titers of the antibody were measured at 4, 20, 30, and 371C, and the antibody was found to have thermal amplitude up to 301C. The antibody reacted with adult, cord, and adult i-positive red blood cells, but failed to react with papaintreated and sialidase-treated red blood cells. These findings strongly suggested that the antibody had the characteristics of an anti-Pr antibody. 5, 6 The patient was treated with a transfusion of warmed red blood cell products, and an increased dose of corticosteroid (1 mg/kg) in addition to avoiding cold exposure. No transfusion-associated reactions were observed. During this period, hemorrhagic cystitis completely improved in a month. Corticosteroid was tapered after a 2-week administration, and cold agglutinin was no longer detected in the patient's serum 3 months after the onset of hemolysis.
CAD is usually observed in association with lymphoproliferative diseases, autoimmune diseases, and infectious diseases. Autoimmune hemolytic anemia including CAD is infrequently reported after allogeneic HSCT. However, a relatively higher incidence of autoimmune hemolytic anemia has been reported in recipients of T-cell-depleted grafts. [1] [2] [3] Therefore, autoimmune hemolytic anemia after allogeneic HSCT is considered a consequence of dysregulated immune reconstitution due to T-cell depletion, GVHD, and possibly immunosuppressive agents such as CSA. However, since HSCT recipients are also susceptible to a variety of pathogens, infectious diseases should be considered a cause of autoimmune hemolytic anemia after HSCT. In our case, CAD occurred simultaneously with adenoviral hemorrhagic cystitis, and had a transient clinical course along with the resolution of hemorrhagic cystitis. Therefore, we think that CAD, in this case, was caused by the adenovirus infection. Among the reported cases of infection-associated CAD, mycoplasma pneumonia and infectious mononucleosis are most frequently observed. To the best of our knowledge, however, infection-associated CAD due to adenovirus has not been reported. Since adenovirus infection is not infrequent after HSCT, transplant physicians should be aware of this unusual complication of adenovirus infection.
The cold-reactive antibody detected in our case was an anti-Pr antibody, which is the third most common antibody causing CAD, following anti-I and anti-i antibodies. 5, 6 Among the anecdotally reported cases of CAD after HSCT, only two cases have been documented to possess anti-Pr antibody. 2, 4 These two patients developed CAD in association with infectious events, pericarditis and cytomegalovirus infection, respectively. Therapy with corticosteroid promptly improved hemolysis in both patients. This finding is in contrast to the cases of CAD caused by other types of antibodies, which have not been associated with infections and have had a uniformly poor outcomes. Therefore, CAD caused by anti-Pr antibody might be a distinct disease entity, particularly after allogeneic HSCT. Further accumulation of such cases is required to elucidate the pathophysiology of CAD after HSCT and its association with adenovirus. 
